Cited by 135Growth Hormone and Insulin-like Growth FactorsHormonal and reproductive studiesPituitary Gland Disorders and Treatments

Growth Hormone and Cardiovascular Risk Factors

Gola, Monica, Bonadonna, Stefania, Doga, Mauro, Giustina, Andrea·2005·The Journal of Clinical Endocrinology & Metabolism

Abstract

The aim of this article is to review the lessons on the relationship between GH and the principal metabolic cardiovascular risk factors that we learned from studies of GH deficiency (GHD) in the adult. The lesson that "organic" GHD has taught us is that primary impairment in the GH/IGF-I axis may lead to a high-risk cardiovascular profile that is partially reversible during GH replacement. Waiting for the definitive demonstration that GH substitution may reduce cardiovascular mortality in these patients, we find that data so far reported are encouraging and indicate in the beneficial cardiovascular effects of GH one of the major factors supporting this type of treatment in hypopituitary GHD adults. Moreover, enough evidence from GHD studies has been produced to suggest a physiological role for the GH/IGF-I axis in the control and regulation of several metabolic cardiovascular risk factors.

Integrity signals

Registry

Crossref · 10.1210/jc.2004-0545

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Surgery and radiotherapy for Cushing disease can cause hypopituitarism, including GH deficiency, which if untreated may alter glucose metabolism and raise cardiovascular risk.

    “Both treatments can cause hypopituitarism (including GH deficiency) that, left untreated, may alter glucose metabolism and raise patients' cardiovascular risk ().”

Cites

Flagged first, then by citations

1 of the 87 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Gola, M., Bonadonna, S., Doga, M., & Giustina, A.
Affiliations
University of Brescia (IT)
Corresponding author
Giustina, Andrea
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2005-03
Volume
90
Issue
3
Pages
1864-1870
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2062026358
Cited by
135
References
87
Citations by year
2026: 1 · 2025: 1 · 2024: 5 · 2023: 3 · 2022: 2 · 2021: 12 · 2020: 4 · 2019: 4 · 2018: 1 · 2017: 7 · 2016: 5 · 2015: 7 · 2014: 7 · 2013: 9 · 2012: 8
FWCI
1.58
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Keywords
growth hormone, cardiovascular risk factors, growth hormone deficiency, insulin-like growth factor I, growth hormone replacement therapy, hypopituitarism, cardiovascular mortality, metabolic risk factors
MeSH terms
Cardiovascular Diseases, Humans, Hypopituitarism, Risk Factors, Human Growth Hormone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review